• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Recent Advances in the Study of Diazene, bis[4-(pentyloxy)phenyl]-, 1-oxide (CAS: 19482-05-4)

Diazene, bis[4-(pentyloxy)phenyl]-, 1-oxide (CAS: 19482-05-4) is a chemical compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential applications. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic uses. The compound's molecular structure, characterized by the presence of diazene and pentyloxy phenyl groups, makes it a promising candidate for various biomedical applications.

Recent studies have explored the synthesis and characterization of Diazene, bis[4-(pentyloxy)phenyl]-, 1-oxide, with a particular emphasis on optimizing its yield and purity. Advanced spectroscopic techniques, including nuclear magnetic resonance (NMR) and mass spectrometry (MS), have been employed to confirm the compound's structure and purity. These studies have also investigated the compound's stability under different environmental conditions, which is crucial for its potential use in pharmaceutical formulations.

In terms of biological activity, preliminary in vitro studies have demonstrated that Diazene, bis[4-(pentyloxy)phenyl]-, 1-oxide exhibits notable antioxidant and anti-inflammatory properties. These findings suggest that the compound could be explored further for its potential role in mitigating oxidative stress and inflammation-related diseases. Additionally, molecular docking studies have indicated that the compound may interact with specific biological targets, such as enzymes involved in inflammatory pathways, providing a mechanistic basis for its observed effects.

Further research has also delved into the compound's potential as a therapeutic agent. For instance, one study investigated its efficacy in animal models of chronic inflammation, reporting a significant reduction in inflammatory markers. Another study explored its potential as an anticancer agent, with results indicating that the compound could induce apoptosis in certain cancer cell lines. These findings, while preliminary, highlight the compound's versatility and warrant further investigation.

Despite these promising results, challenges remain in the development of Diazene, bis[4-(pentyloxy)phenyl]-, 1-oxide as a therapeutic agent. Issues such as bioavailability, toxicity, and long-term safety need to be addressed through comprehensive preclinical and clinical studies. Future research directions may include the development of derivatives with improved pharmacological properties and the exploration of combination therapies to enhance efficacy.

In conclusion, Diazene, bis[4-(pentyloxy)phenyl]-, 1-oxide represents a compound of significant interest in the field of chemical biology and medicinal chemistry. Its unique structural features and promising biological activities make it a valuable candidate for further research and development. Continued efforts to elucidate its mechanisms of action and optimize its therapeutic potential will be crucial in translating these findings into clinical applications.

• 2312-14-3(4,4’-Di-N-dodecyloxyazoxybenzene)
• 2635-26-9(4,4'-Diheptyloxyazoxybenzene)
• 2312-12-1(diazene, bis[4-(decyloxy)phenyl]-, 1-oxide)
• 39350-56-6(Diazene, [4-(heptyloxy)phenyl]phenyl-, monooxide)
• 25729-13-9(4,4'-Dinonyloxyazoxybenzene)
• 2587-42-0(4,4'-Bis(hexyloxy)azoxybenzene)
• 17051-01-3(Diazene, bis(4-butoxyphenyl)-, 1-oxide)
• 2312-13-2(4,4'-diundecoxyazoxybenzene)
• 24387-70-0(Diazene, bis[4-(octadecyloxy)phenyl]-, 1-oxide)
• 25729-12-8(4,4'-Di-n-octyloxyazoxybenzene)